Consensus Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Market Closed - Nyse Other stock markets 21:00:03 28/06/2024 BST			5-day change	1st Jan Change
2.92 ^USD	-3.95%		-4.26%	+93.38%

06-24	Nuvation Bio Inc.(NYSE:NUVB) added to S&P Pharmaceuticals Select Industry Index	CI
06-13	Nuvation Bio Insider Bought Shares Worth $500,089, According to a Recent SEC Filing	MT

Evolution of the average Target Price on Nuvation Bio Inc.

Price target over the last 5 years

History of analyst recommendation changes

7b59cf.JQ8C649F00oY8k5xZzJ3nGn-qWxa0MuT2uDgOeup8g4.bVd0j_UUtC0rvBk2UEYa-hO2_SItpozVm9ORbtn2nE92aEak43CqBmLfJQ~af35e9c1d0b84703112265325e0339ec

Analyst Recommendations on Nuvation Bio Inc.

Nuvation Bio Insider Bought Shares Worth $500,089, According to a Recent SEC Filing	06-13	MT
RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk	04-17	MT
HC Wainwright Adjusts Nuvation Bio's Price Target to $8 From $5, Maintains Buy Rating	03-28	MT
Jefferies Upgrades Nuvation Bio to Buy From Hold, Adjusts Price Target to $10 From $1.40	03-27	MT
BTIG Upgrades Nuvation Bio to Buy From Neutral, Price Target is $5	03-26	MT
H.C. Wainwright Raises Price Target on Nuvation Bio to $5 From $4.50, Maintains Buy Rating	03-07	MT
RBC Cuts Price Target on Nuvation Bio to $4 From $5, Keeps Outperform, Speculative Risk	11-06	MT
RBC Cuts Price Target on Nuvation Bio to $5 From $6, Keeps Outperform, Speculative Risk	05/05/23	MT
Jefferies Downgrades Nuvation Bio to Hold From Buy, Adjusts Price Target to $2 From $5	06/01/23	MT
HC Wainwright Adjusts Price Target on Nuvation Bio to $4.50 From $14, Reiterates Buy Rating	22/08/22	MT
BTIG Downgrades Nuvation Bio to Neutral From Buy	02/08/22	MT
BMO Capital Lowers Nuvation Bio to Market Perform From Outperform, Price Target to $2.50 From $8	02/08/22	MT
Wedbush Adjusts Price Target for Nuvation Bio to $5 From $17 on Discontinuation of NUV-422, Maintains Outperform Rating	01/08/22	MT
RBC Cuts Price Target on Nuvation Bio to $14 From $15, Maintains Outperform Rating, Speculative Risk Qualifier	11/05/22	MT
Wedbush Adjusts Nuvation Bio Price Target to $17 From $23, Maintains Outperform Rating	10/05/22	MT
HC Wainwright Starts Nuvation Bio at Buy With $14 Price Target	04/05/22	MT
BMO Capital Adjusts Nuvation Bio's Price Target to $12 From $17, Keeps Outperform Rating	22/03/22	MT
NUVATION BIO : Wedbush Adjusts Nuvation Bio's Price Target to $23 From $21, Keeps Outperform Rating	13/08/21	MT
NUVATION BIO : Wedbush Adjusts Nuvation Bio's Price Target to $21 From $20, Keeps Outperform Rating	18/05/21	MT
NUVATION BIO : RBC Capital Starts Nuvation Bio at Outperform with $15 Price Target	06/04/21	MT
NUVATION BIO : Jefferies Starts Nuvation Bio at Buy With $20 Price Target	08/03/21	MT
NUVATION BIO : BTIG Initiates Coverage on Nuvation Bio With Buy Rating, Sets Price Target at $16	08/03/21	MT
NUVATION BIO : Cowen Starts Nuvation Bio at Outperform	08/03/21	MT
NUVATION BIO : BMO Capital Starts Nuvation Bio at Outperform With $16 Price Target	08/03/21	MT
NUVATION BIO : Wedbush Starts Nuvation Bio at Outperform With $20 Price Target	08/03/21	MT